Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 1998

View Archived Issues

New therapeutic tetrahydrofuran derivatives from Janssen

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

More dopaminergic agents in the pipeline at Neurogen

Novel CNS agents disclosed by HMR

New agents for cancer discovered at Zeneca

Vertex researchers report 3-D structure of hepatitis C enzyme

New antimalarial agent submitted to extensive clinical testing

Elan and Novartis to develop new formulation of Novartis drug

Clues into the molecular genetics of aging revealed

Artelinic acid: an attractive candidate for development as an antimalarial agent

Preclinical evaluation of leishmaniasis Rx reported

Interim Maxamine phase I data reported

Thienopyridine derivatives for arthritis, osteoporosis from Takeda

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Peptide HIV protease inhibitors claimed by Merck & Co.

Novartis reveals agents for atherosclerosis and chronic inflammation

Lilly reports new benzothiophenes for gynecological and other disorders

Merck subsidiary and Autogen collaborate on obesity research

Lilly discloses novel compounds for influenza

Abbott again extends drug discovery collaboration with ArQule

IGG announces name change

Alza and Janssen E-TRANS pain product collaboration unveiled

Provir set to enter final stage of development for AIDS-related diarrhea

Raloxifene launched in U.S.

Virus Research Institute licenses novel immunotherapeutic delivery system

Cardizem Monovial now available in U.S.

Ground-breaking collaboration in MRI technology announced

Daiichi and Sumitomo to copromote antiallergic drug in Japan

Preclinical and clinical studies presented for RS-8359